Dr Drupad Trivedi
Dr Drupad Trivedi is a post doctoral research associate in Cancer Metabolism and Informatics at Manchester Institute of Biotechnology, Manchester University, funded by Cancer Research, UK. Dr Trivedi graduated in Biomedical Sciences at Middlesex University and immediately followed it up with a PhD in Metabolomics. He completed his doctoral thesis on discovery of Down syndrome biomarkers in maternal urine for prenatal screening of the chromosomal abnormality and then worked as a post doctoral research fellow at London School of Hygiene and Tropical Medicine.
Dr Trivedi has worked as an honorary research fellow for ELK-Foundation of health and biomedical research extending his interest in personalised medicine. Dr Trivedi, also advices and aids in experimental design and method development for metabolomics research at MAP, Diagnostics, UK – for biomarker discovery to screen and diagnose multiple prenatal chromosomal abnormalities during pregnancy.
Currently, Dr Trivedi works in collaboration with scientists at Manchester Cancer Research Centre to compliment proteomics research with his metabolomics output with an objective to discover novel prognostic, predictive and/or pharmacodynamics biomarkers in cancer patients using chromatography and mass spectrometry.
In his current role at BioSpec group led by Prof Royston Goodacre, Dr Trivedi combines his personal research interests in personalised medicine and biomarker discovery from bio-fluids with expertise in various analytical techniques, to undertake metabolomics studies. The wide variety of metabolomics investigative studies focus on central metabolism for cells, biomarker discovery in cancer, therapeutic effects of drugs on metabolism, lipidomics study on drug treatment in mammalian cells and study of algal, bacterial and plant metabolism under intrinsic and extrinsic stress conditions.